Alfica Sehgal, PhD

Judo Bio における Chief Scientific Officer

スピーカー

Alfica is the CSO of Judo Bio working on oligos for therapeutic intervention.

Over the years she has held multiple leadership positions at CAMP4 therapeutics and Alnylam Pharmaceuticals, spanning from early discovery, new target search, platform biology, improvising delivery and leading programs to the clinic. Her experience spans rare liver diseases like Alpha-1 antitrypsin deficiency (Belcesiran), Bleeding disorders (Fitusiran); urea cycle disorders; kidney disease, neurodegenerative and neurodevelopment disorders.

Alfica graduated from TIFR, Mumbai; received her post-doctoral training at Johns Hopkins and Yale University, studying lipid uptake, cholesterol and oxygen homeostasis in parasites, mammalian cells and mice. She has authored more than 60 articles and patents across various disease areas and technologies.